Director · vTv Therapeutics Inc. · vTv Therapeutics Inc. — Director stock option (right to buy)
Side
A
Value
$210K
Shares
6,000
Price
$35.08
Executed
Jun 26, 2026
Disclosed
Jun 29, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Jun 26 executedJun 29, 2026 disclosed
VTVT · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+12 / 25
$210K reported value · 44.3% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
vTv Therapeutics Inc. — Director stock option (right to buy)
Ticker
VTVT
Shares
6,000
Price per share
$35.08
Value
$210,480
Execution date (reported)
Jun 26, 2026
Owned after transaction
19.6K shares
Days from execution to publication
3
Calculation
Value = shares × reported price per share
Shares: 6,000
Price: $35.08
= $210,480
What this establishes
Al-Marzooqi Fahed filed this Form 4 reporting a grant or award of VTVT on Jun 26, 2026. It became public on Jun 29, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Al-Marzooqi Fahedcik:0001928247
Issuer
vTv Therapeutics Inc.cik:0001641489
Revision history · 0
No field has changed since this record was first ingested.
